Following the many recent grants, notices of allowance and intention to grant patents in Europe and ...
Redeye updates its view on Flexion Mobile following its Q4 2024 report, which was softer than expect...
Redeye previews Enea’s Q1 2025 (due on 24 April 2025).
Redeye expects a stable Q1 report from Addnode, with mixed signals in different markets.
Q1'25 numbers due on 29 April at 07:45 CET Adj. EBITDA up by 1% for '25e-'27e Fair value range of SE...
Redeye comments on Flexion Mobile's Q4 2024 report, which came in below our expectations in terms of...
Redeye updates its estimates following Freemelt’s Q4 report, which came in above our expectations in...
Q4 sales pre-announced, SEK -10.7m adj. EBIT in line with ABGSCe Rights issue concluded, 1 Freemelt ...
Redeye comments on Lipigons third quarter report, including positive phase I results for Leaderna, c...
Redeye is positive to Bredband2’s acquisition of 7k fibre customers from Folke AB, with yearly sales...
Acquires 7k fibre customers from Folke AB for SEK 10m (EV) Adds +1% on PF sales Should be clear cost...
Trots en fortsatt substansrabatt på aktien ser vi en attraktiv risk/reward, där den strategiska utve...
Redeye comments on Freemelt’s Q4 results, which were in line with the preliminary figures the compan...
Redeye comments on Lipigon’s fully guaranteed rights issue of SEK37m and how it will impact its base...
Förberedelsekostnaderna tynger fortfarande, men de nya uppdragen rullar samtidigt igång allt fortare...
Redeye provides a research update following the Q4 report recently published by Magle.
Kinda Brave Entertainment Group AB (”Kinda Brave” eller ”Koncernen”) meddelade den 27 mars år 2025 a...
Ph 1b in PD-apathy starts in H2'25 Safety and early efficacy the main goals Comes with USD 4.
Redeye initiates coverage of Lime Technologies, a full-service SaaS CRM provider focused on specific...
We lower adjusted EBITA by 6-11% for 2025E-27E, owing to recent FX movements, while we take a somewh...
